USD 84.74
(-0.94%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.32 Billion USD | 10.06% |
2022 | 2.1 Billion USD | 11.06% |
2021 | 1.89 Billion USD | 15.51% |
2020 | 1.64 Billion USD | 9.24% |
2019 | 1.5 Billion USD | 4.51% |
2018 | 1.44 Billion USD | 10.51% |
2017 | 1.3 Billion USD | 7.95% |
2016 | 1.2 Billion USD | 5.05% |
2015 | 1.14 Billion USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.33 Billion USD | 0.56% |
2024 Q1 | 2.31 Billion USD | -0.1% |
2023 Q2 | 2.26 Billion USD | 2.28% |
2023 Q1 | 2.21 Billion USD | 5.13% |
2023 Q3 | 2.32 Billion USD | 2.31% |
2023 FY | 2.32 Billion USD | 10.06% |
2023 Q4 | 2.32 Billion USD | 0.04% |
2022 FY | 2.1 Billion USD | 11.06% |
2022 Q4 | 2.1 Billion USD | 4.87% |
2022 Q2 | 1.98 Billion USD | 2.05% |
2022 Q1 | 1.94 Billion USD | 2.58% |
2022 Q3 | 2.01 Billion USD | 1.16% |
2021 FY | 1.89 Billion USD | 15.51% |
2021 Q4 | 1.89 Billion USD | 1.77% |
2021 Q1 | 1.68 Billion USD | 2.19% |
2021 Q2 | 1.8 Billion USD | 7.44% |
2021 Q3 | 1.86 Billion USD | 3.38% |
2020 Q2 | 1.65 Billion USD | 8.15% |
2020 FY | 1.64 Billion USD | 9.24% |
2020 Q4 | 1.64 Billion USD | -0.24% |
2020 Q3 | 1.64 Billion USD | -0.6% |
2020 Q1 | 1.53 Billion USD | 1.86% |
2019 Q1 | - USD | -100.0% |
2019 FY | 1.5 Billion USD | 4.51% |
2019 Q4 | 1.5 Billion USD | -0.4% |
2019 Q3 | 1.51 Billion USD | 1.48% |
2019 Q2 | 1.48 Billion USD | 0.0% |
2018 Q3 | 1.44 Billion USD | 0.0% |
2018 FY | 1.44 Billion USD | 10.51% |
2018 Q1 | - USD | -100.0% |
2018 Q4 | 1.44 Billion USD | -0.55% |
2017 Q4 | 1.3 Billion USD | 0.0% |
2017 FY | 1.3 Billion USD | 7.95% |
2016 FY | 1.2 Billion USD | 5.05% |
2015 FY | 1.14 Billion USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AptarGroup, Inc. | 513.05 Million USD | -352.432% |
Baxter International Inc. | 2.82 Billion USD | 17.804% |
Becton, Dickinson and Company | 3.27 Billion USD | 29.08% |
Bausch + Lomb Corporation | 1.02 Billion USD | -125.799% |
Haemonetics Corporation | 317.2 Million USD | -631.778% |
Envista Holdings Corp | 258.8 Million USD | -796.914% |
ResMed Inc. | 822.25 Million USD | -182.3% |
Teleflex Incorporated | 626.21 Million USD | -270.673% |
Warby Parker Inc. | 62.23 Million USD | -3629.816% |
West Pharmaceutical Services, Inc. | 434.7 Million USD | -433.981% |